首页> 美国政府科技报告 >HTLV-I (Human T-Cell Leukemia Virus 1) Seroconversion Study
【24h】

HTLV-I (Human T-Cell Leukemia Virus 1) Seroconversion Study

机译:HTLV-I(人T细胞白血病病毒1)血清转化研究

获取原文

摘要

A data collection research center has been established on Okinawa for the purpose of studying the risk of HTLV-I transmission to active duty personnel stationed there. Research activities include a period prevalence serosurvey for HTLV-I in 5,267 personnel. Thirty-one of this group were positive by ELISA with confirmatory tests and full laboratory epidemiologic analysis pending. In addition, active duty personnel are being accessioned on arrival to Okinawa for prospective follow-up with repeat serologies and questionnaires throughout their tours to determine rates of seroconversion. Greater than 700 participants are currently accessioned. Preliminary results from the seroprevalence survey suggest that transmission rates may be low. However, final conclusions must await completion of the analysis of the seroprevalence draw and prospective study of personnel during their tours. HTLV-I, the first human retrovirus isolated, has been identified as the etiologic agent for Adult T-Cell Leukemia/Lymphoma (ATLL). In addition, HTLV-I has been linked etiologically to a subset of patients with tropical Spastic Paraparesis (TSP) - a slowly progressive myelopathy. Transmission of the virus occurs parenterally, sexually, and from mother to child (predominantly via breast feeding). Keywords: Epidemiology; Sexually transmitted diseases. (AW)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号